Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $1.58 per share versus the Zacks Consensus Estimate of a loss of $1.18. This compares to loss of $1.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -33.90%. A quarter ago, it was expected that this biotechnology company would post a loss of $2.11 per share when it actually produced a loss of $1.33, delivering a surprise of 36.97%.Over the last four quarters, th ...